Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2008-07-01
2008-07-01
Jiang, Shaojia Anna (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C536S001110
Reexamination Certificate
active
07393836
ABSTRACT:
A D-Xylopyranosyl-substituted phenyl compound of general formula Iwherein the groups R1to R5, X, Z and R7a, R7b, R7care defined as in claim 1, have an inhibiting effect on the sodium-dependent glucose cotransporter SGLT. The present invention also relates to pharmaceutical compositions for the treatment of metabolic disorders.
REFERENCES:
patent: 6414126 (2002-07-01), Ellsworth et al.
patent: 2006/0019948 (2006-01-01), Eckhardt et al.
patent: WO 98/31697 (1998-07-01), None
patent: WO 01/27128 (2001-04-01), None
patent: WO 02/083066 (2002-10-01), None
patent: WO 03/099836 (2003-12-01), None
patent: WO 2004/013118 (2004-02-01), None
patent: WO 2004/052902 (2004-06-01), None
patent: WO 2004/052903 (2004-06-01), None
patent: WO 2004/080990 (2004-09-01), None
patent: WO 2005/012326 (2005-02-01), None
Adachi et al., “T-1095, a Renal Na+-Glucose Transport Inhibitor”, Metabolism, vol. 49 (8), 2000, 990-995.
Barsoumian Edward Leon
Eckhardt Matthias
Eickelmann Peter
Himmelsbach Frank
Thomas Leo
Boehringer Ingelheim International GmbH
Devlin Mary-Ellen M.
Dow David A.
Jiang Shaojia Anna
McIntosh III Traviss C.
LandOfFree
D-xylopyranosyl-substituted phenyl derivatives, medicaments... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with D-xylopyranosyl-substituted phenyl derivatives, medicaments..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and D-xylopyranosyl-substituted phenyl derivatives, medicaments... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2810830